The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics

The current pandemic of coronavirus disease (COVID-19) caused by SARS-CoV-2 is a significant global health challenge. A recent study by Carvelli and colleagues now demonstrates the involvement of complement C5a and its receptor C5aR1 in disease progression and suggests that blockade of the C5a-C5aR1...

Descripción completa

Detalles Bibliográficos
Autores principales: Woodruff, Trent M., Shukla, Arun K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Spotlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510552/
https://www.ncbi.nlm.nih.gov/pubmed/33023856
http://dx.doi.org/10.1016/j.it.2020.09.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510552/
https://www.ncbi.nlm.nih.gov/pubmed/33023856
http://dx.doi.org/10.1016/j.it.2020.09.008

Ejemplares similares